Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2008-03-28Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization: Multicenter Collaborative Study
-
CLINICAL_TRIALS study record update · 2008-01-16Observational Study of Production of IFN-Gamma by Peripheral Lymphocytes in Response to Specific Antigens Before and After Treatment for Tuberculosis
-
CLINICAL_TRIALS study record update · 2007-11-19Effect of Continuous Positive Airway Pressure on Fluid Absorption Among Patients With Pleural Effusion Due to Tuberculosis
-
CLINICAL_TRIALS study record update · 2007-11-14Production of Gamma-Interferon by Circulating Lymphocytes Exposed to Antigens Specific of Mycobacterium Tuberculosis: Contribution to the Identification of Latent Tuberculosis Infection in Contact Tracing
-
CLINICAL_TRIALS study record update · 2007-10-30Follow up of Autoantibodies in Active Tuberculosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2007-10-24Effect of the South African Public Sector Antiretroviral Treatment Programme on the Performance of Tuberculosis and Immunization Programmes - A Cluster Controlled (Non-Randomized) Trial
-
CLINICAL_TRIALS study record update · 2007-09-18Impact of Tuberculosis on HIV Infection in Uganda
-
CLINICAL_TRIALS study record update · 2007-06-26Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in the Assessment of Latent Mycobacterium Tuberculosis Infection in Patients Candidate to Treatment or Treated With TNFα Antagonists
-
CLINICAL_TRIALS study record update · 2007-05-31A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Are Latently Infected With Mycobacterium Tuberculosis.
-
CLINICAL_TRIALS study record update · 2007-04-05Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
-
CLINICAL_TRIALS study record update · 2007-02-12Food Incentives for TB Treatment Compliance in East Timor
-
CLINICAL_TRIALS study record update · 2007-01-29A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously
-
CLINICAL_TRIALS study record update · 2007-01-29A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
-
CLINICAL_TRIALS study record update · 2007-01-18A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
-
CLINICAL_TRIALS study record update · 2007-01-18A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
-
CLINICAL_TRIALS study record update · 2007-01-08Effects of Vitamin D Supplementation on Antimycobacterial Immunity: A Randomised Trial
-
CLINICAL_TRIALS study record update · 2006-12-15Investigation of a Novel Approach to Improve Adherence to Treatment and Treatment Success Rates for Tuberculosis Patients in Senegal
-
CLINICAL_TRIALS study record update · 2006-09-13International Multicenter Trial for the Evaluation of a Four-Drug Fixed Dose Combined Tablet Daily in the Initial Intensive Phase of Chemotherapy Followed by a Two-Drug Fixed Dose Combined Tablet Three Times a Week in the Continuation Phase for the Treatment of Pulmonary Tuberculosis